Hsiang-I Tsai

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 3

Top Topics

Regulatory T Cells

Dendritic Cells

Kidney Transplantation

Top Venues

EMBO molecular medicine

Biomaterials science

This page only lists publications with an associated author ORCID identifier.

Publications

Min Yang, Zhanxue Xu, Hailan Yan, Hsiang-I Tsai, Dandan Su, Fuxia Yan, Qiumei Lu, Jianhua Feng, Weiwei Zeng, Lifang Xi, Hualian Zha, Yunzhi Ling, Chao He, Yingyi Wu, Xiaowei Xu, Gang Zheng, Gan Liu, Hongbo Chen, Fang Cheng
PD-L1 cellular nanovesicles carrying rapamycin inhibit alloimmune responses in transplantation. Biomaterials science 9 (4) (2021)
Hsiang-I Tsai, Xiaobin Zeng, Longshan Liu, Shengchang Xin, Yingyi Wu, Zhanxue Xu, Huanxi Zhang, Gan Liu, Zirong Bi, Dandan Su, Min Yang, Yijing Tao, Changxi Wang, Jing Zhao, John E Eriksson, Wenbin Deng, Fang Cheng, Hongbo Chen
NF45/NF90-mediated rDNA transcription provides a novel target for immunosuppressant development. EMBO molecular medicine 13 (3) (2021)
Zhanxue Xu, Hsiang-I Tsai, Youmei Xiao, Yingyi Wu, Dandan Su, Min Yang, Hualian Zha, Fuxia Yan, Xiaoyan Liu, Fang Cheng, Hongbo Chen
Engineering Programmed Death Ligand-1/Cytotoxic T-Lymphocyte-Associated Antigen-4 Dual-Targeting Nanovesicles for Immunosuppressive Therapy in Transplantation. ACS nano 14 (7) (2020)